Newsmeme!
Discover News you didn't know existed
Non-hodgkin's Lymphoma
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Genentech Has Mixed Results In Cancer Fight
Published October 8, 2008, 3:23 am, Forbes
Genentech-Biogen rheumatoid arthritis drug slows progression of lymphocytic leukemia, but trial of lung cancer treatment fails.
Phase III study shows rituximab delays disease progression in leukaemia patients
Published October 7, 2008, 10:48 pm, PharmaBiz
Roche announced that a Phase III study investigating MabThera (rituximab) in combination with chemotherapy has shown a significant improvement in progression free survival in patients with relapsed or refractory Chronic Lymphocytic Leukaemia (CLL), the most common form of adult leukaemia.
TOOHEY: Colleluori Classic will lay it on the lime
Published October 7, 2008, 10:20 pm, Delaware County Times
Pat Colleluori could not believe his eyes when he turned on his television last spring to watch Hofstra knock off Drexel in the Colonial Athletic Association men's lacrosse championship game.
Things to do from Oct. 8, 2008
Published October 7, 2008, 10:10 pm, The Sharon Herald
• There will be a fundraiser for the American Cancer Society from 10 a.m. to 9 p.m. Friday at Something’s Brewin’ in the Shenango Valley Mall, Hermitage. For a $15 donation you will receive unlimited coffee or tea, a luncheon tray, and tickets for a Chinese auction.
Staff Writer
Published October 7, 2008, 6:02 pm, BioWorld
Genentech Inc. and Biogen Idec Inc. said their investigational leukemia drug Rituxan (rituximab) passed a second Phase III study, meeting its primary goal of improving the period of time before the disease progresses compared to chemotherapy alone.
Good News For Rituxan
Published October 7, 2008, 2:15 pm, Forbes
Genentech and Biogen's rheumatoid arthritis drug slows the progression of lymphocytic leukemia, studies show.
Biogen drug has strong clinical showing as leukemia medicine
Published October 7, 2008, 12:03 pm, Triangle Business Journal
A lymphoma treatment developed by Biogen Idec has shown strong promise in a late-stage human clinical trial as a leukemia treatment. (DNA)
Genentech touts test of Rituxan plus chemo vs. leukemia
Published October 7, 2008, 12:02 pm, BizJournals
Biotech giant Genentech Inc. and partner Biogen Idec said a combined treatment of Rituxan and chemotherapy did well in patients with chronic lymphocytic leukemia, the most common adult leukemia. (DNA)
Genentech And Biogen Score Against Leukemia
Published October 7, 2008, 9:30 am, Forbes
Companies' arthritis drug helps patients with stubborn strains of blood cancer.
Phase III Study Showed Rituxan Combined With Chemotherapy Improved Progression-Free Survival In Patients With Relapsed ...
Published October 7, 2008, 9:22 am, Medical News Today
Genentech, Inc.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |